Published :
Tables : 52
Figures : 56
Category : Healthcare
No. of Pages : 200
Report Code : HC-1199
In-vitro Toxicology Testing Market is estimated to value over USD 9.8 billion by 2027 end and is expected to register a CAGR of over 11% during the forecast period 2020 to 2027. In-vitro process is used to detect hazardous chemical substances over an isolated part of an organism. It helps in detecting the toxicity levels at early developmental stages of products like cosmetics, drugs and food additives. In-vitro toxicology involved the usage of tissues or cells that are maintained or grown in a controlled laboratory environment to examine the toxic properties of different mixtures and compounds. This testing method is primarily used for safety evaluation in drug development. It is also used for ranking chemicals based on their potency. Moreover, in-vitro toxicology testing can be used for determining dose-response, absorption, distribution, metabolism, excretion (ADME) and threshold response of drug. In-vitro Toxicology Testing Market Segmentation: Depending on the technology, the market is bifurcated into cell culture technology, high throughput technology, OMICS technology and molecular imaging. Cell culture technology segment is expected to witness significant market growth during the forecast period. There have been recent advancements in the exposure of human cell culture along with test systems. This has allowed for the development and expansion of in-vitro assay systems which are demonstrative, predictive and are suitable for toxicity testing of a wide range of chemicals including airborne materials and nanomaterials. Method-wise, the market is categorised as cellular assays, biochemical assays, ex-vivo and in-silico segment. Ex-vivo method is projected to register a noteworthy growth rate during the forecast period. This is mainly due to the increasing popularity of stem cell therapy which has encouraged scientists to implement this technique. Based on the type of application, the market is bifurcated into systemic toxicology, dermal toxicity, endocrine disruption and occular toxicity. There are different types of systemic toxicity like sub-acute systemic toxicity, acute systemic toxicity, chronic systemic toxicity and sub-chronic systemic toxicity. Such a plethora of options in one method is the primary reason for the segment to thrive. Basis the end-use, the market is categorised as pharmaceutical industry, cosmetic & household products, diagnostics, chemical industry and food industry. The chemical industry is anticipated to showcase significant market growth due to the increase in the manufacturing of excipients for pharmaceutical and cosmetics formulations. Furthermore, the presence of a substantial product portfolio for the market will surely trigger the scope of applications of these assays in the industry. The market is regionally categorised as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Asia Pacific is projected to showcase significant market growth over the forecast period owing to growing research and development in pharmaceuticals coupled with consistent improvement in healthcare infrastructure. Furthermore, clinical trials are conducted at a relatively low cost than western countries. It is therefore anticipated that many globalised companies will be willing to invest massively in the Asia Pacific region. Some of the key market players include: Agilent Technologies Inc., Abbott Laboratories (Alere Inc.), Bio-Rad Laboratories Inc., Merck KGaA, Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Catalent Inc., Eurofins Scientific, GE Healthcare, Quest Diagnostics Inc., LabCorp and EVOTEC. In-vitro Toxicology Testing Market Segmentation: By Technology Cell Culture Technology High Throughput Technology Molecular Imaging OMICS Technology By Method Cellular Assays Biochemical Assays In-silico Ex-vivo By Application Systemic Toxicology Dermal Toxicity Endocrine Disruption Occular Toxicity By End Use Pharmaceutical Industry Cosmetic & Household Products Diagnostics Chemical Industry Food Industry By Region North America Europe Asia Pacific Latin America Middle East & Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Animal welfare agencies are considering to completely replace conventional animal testing to in-vitro toxicology testing method and this paradigm shift will surely augment the market significantly Objectives of the Study: To provide with an exhaustive analysis on the in-vitro toxicology testing market by technology, by method, by application, by end use and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
In-vitro process is used to detect hazardous chemical substances over an isolated part of an organism. It helps in detecting the toxicity levels at early developmental stages of products like cosmetics, drugs and food additives. In-vitro toxicology involved the usage of tissues or cells that are maintained or grown in a controlled laboratory environment to examine the toxic properties of different mixtures and compounds.
This testing method is primarily used for safety evaluation in drug development. It is also used for ranking chemicals based on their potency. Moreover, in-vitro toxicology testing can be used for determining dose-response, absorption, distribution, metabolism, excretion (ADME) and threshold response of drug.
In-vitro Toxicology Testing Market Segmentation:
Depending on the technology, the market is bifurcated into cell culture technology, high throughput technology, OMICS technology and molecular imaging. Cell culture technology segment is expected to witness significant market growth during the forecast period. There have been recent advancements in the exposure of human cell culture along with test systems. This has allowed for the development and expansion of in-vitro assay systems which are demonstrative, predictive and are suitable for toxicity testing of a wide range of chemicals including airborne materials and nanomaterials.
Method-wise, the market is categorised as cellular assays, biochemical assays, ex-vivo and in-silico segment. Ex-vivo method is projected to register a noteworthy growth rate during the forecast period. This is mainly due to the increasing popularity of stem cell therapy which has encouraged scientists to implement this technique.
Based on the type of application, the market is bifurcated into systemic toxicology, dermal toxicity, endocrine disruption and occular toxicity. There are different types of systemic toxicity like sub-acute systemic toxicity, acute systemic toxicity, chronic systemic toxicity and sub-chronic systemic toxicity. Such a plethora of options in one method is the primary reason for the segment to thrive.
Basis the end-use, the market is categorised as pharmaceutical industry, cosmetic & household products, diagnostics, chemical industry and food industry. The chemical industry is anticipated to showcase significant market growth due to the increase in the manufacturing of excipients for pharmaceutical and cosmetics formulations. Furthermore, the presence of a substantial product portfolio for the market will surely trigger the scope of applications of these assays in the industry.
The market is regionally categorised as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Asia Pacific is projected to showcase significant market growth over the forecast period owing to growing research and development in pharmaceuticals coupled with consistent improvement in healthcare infrastructure. Furthermore, clinical trials are conducted at a relatively low cost than western countries. It is therefore anticipated that many globalised companies will be willing to invest massively in the Asia Pacific region.
Some of the key market players include:
Agilent Technologies Inc., Abbott Laboratories (Alere Inc.), Bio-Rad Laboratories Inc., Merck KGaA, Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Catalent Inc., Eurofins Scientific, GE Healthcare, Quest Diagnostics Inc., LabCorp and EVOTEC.
By Technology
By Method
By Application
By End Use
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Animal welfare agencies are considering to completely replace conventional animal testing to in-vitro toxicology testing method and this paradigm shift will surely augment the market significantly
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global In-vitro Toxicology Testing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global In-vitro Toxicology Testing Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of In-vitro Toxicology Testing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global In-vitro Toxicology Testing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global In-vitro Toxicology Testing Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Cell Culture Technology 7.2. High Throughput Technology 7.3. Molecular Imaging 7.4. OMICS Technology 8. Global In-vitro Toxicology Testing Market, By Method Historical Analysis and Forecast 2020-2027 (USD Million) 8.1 Cellular Assays 8.2 Biochemical Assays 8.3 In-silico 8.4 Ex-vivo 9. Global In-vitro Toxicology Testing Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Systemic Toxicology 9.2. Dermal Toxicity 9.3. Endocrine Disruption 9.4. Occular Toxicity 10. Global In-vitro Toxicology Testing Market, By End Use Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Pharmaceutical Industry 10.2. Cosmetic & Household Products 10.3. Diagnostics 10.4. Chemical Industry 10.5. Food Industry 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1 Agilent Technologies Inc. 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 Abbott Laboratories (Alere Inc.) 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Bio-Rad Laboratories Inc. 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 Merck KGaA 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Charles River Laboratories International Inc. 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Thermo Fisher Scientific Inc. 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Catalent Inc. 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Eurofins Scientific 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 GE Healthcare 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 Quest Diagnostics Inc. 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 LabCorp 16.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 Evotec 16.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 17. Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics